About Amy Farabaugh, PhD
Dr Amy Farabaugh is an Assistant Professor of Psychiatry at Harvard Medical School. She is also the Director of Psychotherapy Research for the Depression Clinical & Research Program.
Dr Farabaugh received her BA from the University of Notre Dame and her PhD from Northeastern University. She completed her pre-doctoral internship at the Brockton/West Roxbury VAMC / Harvard Medical School (HMS), and her postdoctoral fellowship at the Massachusetts General Hospital (MGH) Depression Clinical and Research Program (DCRP).
Clinical Interests:
- Anxiety disorders
- Major depressive disorder
- Psychosocial Interventions
Treats:
- Adult
Locations
Mass General Psychiatry: Depression Clinical & Research Program
One Bowdoin Square
6th Floor
Boston, MA 02114
Phone: 617-726-8895
Medical Education
- PhD, Northeastern University **
Accepted Insurance Plans
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Carelon Behavioral Health
- Commonwealth Care Alliance
- Coventry
- Evernorth Behavioral Health
- Harvard Pilgrim Health Care
- Humana
- MassHealth
- Medicaid ME
- Medicare
- Medicare ACO
- Multiplan
- Senior Whole Health
- TriCare
- United Behavioral Health
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Although Dr Farabaugh currently serve as a co-investigator on a variety of studies involving psychopharmacological treatment and involving screening for depression and suicidality, the focus of her research is on psychotherapeutic treatments for patients with major depressive disorder (MDD) and for patients with MDD with comorbid medical conditions. She has served as an investigator providing protocol-driven cognitive behavior therapy (CBT) for research patients in the NIMH supported treatment resistant depression study, Sequenced Treatment Alternatives to Relieve Depression (STAR*D). She was funded through a Kaplen Fellowship (Harvard Medical School) to examine the prevalence rate of MDD in Parkinson's Disease (PD) and the feasibility of the CBT approach in the treatment of depression in patients with PD. The findings from the pilot study were promising, indicating that CBT may be an appropriate and effective treatment for MDD in PD. In 2007, she was awarded a K-23 mentored award from NIMH to further investigate CBT for depression in PD. Dr Farabaugh was also awarded a NARSAD to look at QEEG as a predictor of psychotherapy.
Publications
-
View my publications at PubMed